Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Single-group Target Study to Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer

NCT04520906 is registered in ClinicalTrials.gov with Suzhou Hengruihongyuan Medical Technology Co. LTD as lead sponsor.

NCT NCT04520906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04520906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Single-group Target Study to Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
Lead sponsor
Suzhou Hengruihongyuan Medical Technology Co. LTD
Phase
Not applicable
Overall status
Terminated
Start date
December 17, 2020
Completion date
April 1, 2023
Enrollment
61 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma